Ruscheweyh Ruth, Lutz Jürgen, Mehrkens Jan-Hinnerk
Neurologische Klinik, Klinikum der Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, München, Deutschland.
Radiologisches Zentrum München (RZM), Pippingerstr. 25, 81245, München, Deutschland.
Schmerz. 2020 Dec;34(6):486-494. doi: 10.1007/s00482-020-00496-4. Epub 2020 Sep 22.
The present article gives an update of relevant aspects in the diagnosis and therapy of trigeminal neuralgia from the neurological, neuroradiological and neurosurgical point of view. The diagnosis of trigeminal neuralgia is clinical, but high-quality imaging is mandatory to identify secondary causes and a neurovascular contact. New methods such as DTI (diffusion tensor imaging) allow a more differentiated assessment of the consequences of a vascular contact on the trigeminal nerve. Carbamazepine and oxcarbazepine continue to be first choice for the medical treatment, but have been supplemented by additional options such as pregabaline, lamotrigine, and onabotulinumtoxin A. In patients insufficiently responding to medical treatment, there are neurosurgical treatment options giving very good results. The best long-term results have been described for microvascular decompression, but percutaneous and radiosurgical treatments also are good options, especially in patients with an increased surgical risk profile, in secondary trigeminal neuralgia, and in case of recurrence after microvascular decompression.
本文从神经学、神经放射学和神经外科的角度,对三叉神经痛诊断与治疗的相关方面进行了更新。三叉神经痛的诊断主要依靠临床,但高质量成像对于识别继发原因和神经血管接触至关重要。诸如扩散张量成像(DTI)等新方法能够更有区分性地评估血管接触对三叉神经的影响。卡马西平和奥卡西平仍是药物治疗的首选,但已补充了加巴喷丁、拉莫三嗪和A型肉毒毒素等其他选择。对于药物治疗反应欠佳的患者,有多种神经外科治疗方案可取得很好的效果。微血管减压术的长期效果最佳,但经皮治疗和放射外科治疗也是不错的选择,尤其是对于手术风险增加的患者、继发性三叉神经痛患者以及微血管减压术后复发的患者。